Veeva and Zifo Partner to Accelerate Quality Control Modernization
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) and Zifo announced a product partnership aimed at modernizing quality control operations in biopharma. The integration combines Veeva LIMS with Zifo's data integration platform, qcKen, enabling direct data import from any source document or other LIMS systems.
The partnership will simplify master data configuration during LIMS implementation and site deployment, helping companies transition from legacy QC systems. The collaboration focuses on streamlining test and specification data creation, expediting implementation processes, and delivering faster ROI for new Veeva LIMS customers.
As part of the agreement, Zifo becomes an official Veeva Product Partner, expanding their existing relationship as a Veeva Services Partner. The integration aims to support GMP quality business processes with greater accuracy while helping organizations increase scale and speed batch release cycles.
Positive
- Strategic partnership enhances Veeva's LIMS offering with data integration capabilities
- Potential for faster customer implementation and ROI generation
- Expansion of existing partnership indicates strong business relationship
Negative
- None.
News Market Reaction
On the day this news was published, VEEV declined 2.66%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Integration will reduce the burden of master lab data configuration, lowering costs and speeding Veeva LIMS implementation
"We are excited to partner with Veeva to offer powerful solutions to the life sciences industry," said Kannan Jagamoorthy, general manager and head of Zifo North America. "Our collaboration will help customers expedite their adoption of Veeva LIMS to streamline operations."
With Veeva, companies take a holistic approach to quality assurance (QA) and QC to support GMP quality business processes with greater accuracy. Using Zifo's qcKen will help accelerate test and specification data creation, streamline implementation and site deployments, and deliver a faster return on investment for new Veeva LIMS customers.
"Veeva LIMS is designed specifically for life sciences organizations looking to advance their QC operations, increase scale, and speed batch release cycles," said Ashley McMillan, senior director, Veeva LIMS strategy. "Partnering with Zifo allows customers to implement Veeva LIMS and realize value much quicker, accelerating QC modernization initiatives."
As part of the partnership, Zifo is an official Veeva Product Partner, building on its existing relationship as a Veeva Services Partner. Watch this to learn how a unified cloud LIMS can improve right first time and accelerate batch release.
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
About Zifo
Zifo is the leading global enabler of AI and data-driven enterprise informatics for science-driven organizations. With extensive solutions and services expertise spanning research, development, manufacturing, and clinical domains, we serve various industries, including pharma, biotech, chemicals, food and beverage, oil and gas, and FMCG. Trusted by over 190 science-focused organizations worldwide, Zifo is the partner of choice for advancing digital scientific innovation. For more information, visit zifornd.com.
Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10- Q for the period ended October 31, 2024, which you can find here (a summary of risks which may impact our business can be found on pages 36 and 37), and in our subsequent SEC filings, which you can access at sec.gov.
Contact:
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/veeva-and-zifo-partner-to-accelerate-quality-control-modernization-302358419.html
SOURCE Veeva Systems
FAQ
What is the purpose of the Veeva Systems (VEEV) and Zifo partnership announced in January 2024?
How will the Veeva LIMS and Zifo integration benefit biopharma companies?
What is Zifo's new role in the partnership with Veeva Systems (VEEV)?
How does the Veeva-Zifo partnership affect LIMS implementation time and ROI?
